JScopeJapan Capex

Daiichi Sankyo

TSE 45684 tracked projects¥133B disclosed

Sectors

Pharma & Medical, R&D Facilities

Where it builds

Brazil, China, Tokyo, Gunma

Stage

2 planned · 2 building

Every tracked project

4
PostedProjectSectorLocationInvestmentPhase
2026.08.12Daiichi Sankyo to expand manufacturing equipment at Alphaville plant in Sao Paulo, BrazilDaiichi Sankyo Brazil Ltda. plans to expand manufacturing equipment at its Alphaville plant in Sao Paulo, Brazil. The project has a total planned investment of ¥10.512 billion, with construction scheduled from June 2023 through April 2027; production capacity will be expanded after completion.Pharma & MedicalSao Paulo, Brazil¥10.5BBuilding
2026.08.12Daiichi Sankyo to install new manufacturing equipment at Shanghai plantDaiichi Sankyo plans to invest JPY 27.189 billion in new manufacturing equipment at its Shanghai plant in China. Construction began in July 2024, with completion scheduled for May 2030; the disclosure identifies the post-completion increase in capacity as new capacity.Pharma & MedicalShanghai, China¥27.2BBuilding
2026.08.09Daiichi Sankyo to expand research facilities at Shinagawa R&D CenterDaiichi Sankyo plans to invest ¥88.891 billion in new research equipment at its Shinagawa Research and Development Center in Shinagawa, Tokyo. Construction began in November 2024 and completion is scheduled for December 2027, with the project funded internally.R&D FacilitiesShinagawa, Tokyo¥88.9BPlanned
2026.08.09Daiichi Sankyo to upgrade manufacturing equipment at Tatebayashi PlantDaiichi Sankyo plans to invest ¥6.43 billion in manufacturing equipment at its Tatebayashi Plant in Chiyoda, Gunma. Construction is scheduled to begin in March 2026 and finish in August 2027; the disclosure describes the post-completion capacity increase as refurbishment.Pharma & MedicalChiyoda, Gunma¥6.4BPlanned

Also building in Pharma & Medical

Browse the sector: Pharma & Medical, R&D Facilities.